Correlation Between AIM ImmunoTech and Addex Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AIM ImmunoTech and Addex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AIM ImmunoTech and Addex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AIM ImmunoTech and Addex Therapeutics, you can compare the effects of market volatilities on AIM ImmunoTech and Addex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AIM ImmunoTech with a short position of Addex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AIM ImmunoTech and Addex Therapeutics.

Diversification Opportunities for AIM ImmunoTech and Addex Therapeutics

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between AIM and Addex is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding AIM ImmunoTech and Addex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Addex Therapeutics and AIM ImmunoTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AIM ImmunoTech are associated (or correlated) with Addex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Addex Therapeutics has no effect on the direction of AIM ImmunoTech i.e., AIM ImmunoTech and Addex Therapeutics go up and down completely randomly.

Pair Corralation between AIM ImmunoTech and Addex Therapeutics

Considering the 90-day investment horizon AIM ImmunoTech is expected to under-perform the Addex Therapeutics. In addition to that, AIM ImmunoTech is 1.06 times more volatile than Addex Therapeutics. It trades about -0.34 of its total potential returns per unit of risk. Addex Therapeutics is currently generating about 0.07 per unit of volatility. If you would invest  853.00  in Addex Therapeutics on November 28, 2024 and sell it today you would earn a total of  47.00  from holding Addex Therapeutics or generate 5.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

AIM ImmunoTech  vs.  Addex Therapeutics

 Performance 
       Timeline  
AIM ImmunoTech 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days AIM ImmunoTech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Addex Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Addex Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Addex Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

AIM ImmunoTech and Addex Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AIM ImmunoTech and Addex Therapeutics

The main advantage of trading using opposite AIM ImmunoTech and Addex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AIM ImmunoTech position performs unexpectedly, Addex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will offset losses from the drop in Addex Therapeutics' long position.
The idea behind AIM ImmunoTech and Addex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stocks Directory
Find actively traded stocks across global markets